Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Iovance Biotherapeutics (Silver).

VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.

Share this video  

UKOF 2018 | PEACE and TRACERx: dissecting metastases and intra-tumor heterogeneity

Mariam Jamal-Hanjani, BSc, MBBS, PhD, of University College London, London, UK, discusses her talk regarding intra-tumor heterogeneity within lung cancer at the UK Oncology Forum (OF) 2018, held in Liverpool, UK. She highlights the significance of longitudinal studies, such as TRACERx (NCT01888601) and PEACE (NCT03004755), in which tissue samples are collected from patients to map the evolution of cancers from diagnosis through to relapse, metastasis and death. These facilitate our understanding of how not only lung cancers, but tumors in general spread. Dr Jamal-Hanjani further discusses the logistics surrounding longitudinal studies, including funding and the integration of clinical and scientific communities.

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.